713 results on '"Rodriguez, Paulo"'
Search Results
2. Pan-cancer γδ TCR analysis uncovers clonotype diversity and prognostic potential
3. Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma
4. Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages
5. PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing
6. Enniatin A inhibits the chaperone Hsp90 and unleashes the immune system against triple-negative breast cancer
7. Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers
8. Giraldo Ángel, Jaime : Born in Anserma (Colombia), September 15, 1929, Died in Cota (Colombia), August 23, 2014
9. Affinity-matured DLL4 ligands as broad-spectrum modulators of Notch signaling
10. Decoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity
11. Increased inflammatory low-density neutrophils in severe obesity and effect of bariatric surgery: Results from case-control and prospective cohort studies
12. Introduction to the special issue: B cells in cancer immunosurveillance
13. STORYTELLING EM A RAINHA DE KATWE
14. IgA transcytosis and antigen recognition govern ovarian cancer immunity
15. Oncolytic Virotherapy Combined with Nivolumab Elicits Complete Responses in Muscle-Invasive Bladder Cancer in Association with the Formation of Tertiary Lymphoid Structures
16. MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects
17. Transgelin 2 guards T cell lipid metabolic programming and anti-tumor function
18. Differential requirements for CD4+ T cells in the efficacy of the anti-PD-1+LAG-3 and anti-PD-1+CTLA-4 combinations in melanoma flank and brain metastasis models
19. Notch Signaling: A Pivot Regulator of Adaptive and Innate Immunity
20. Cosmological Bianchi Class A models in S\'aez-Ballester theory
21. Crystal Structure of Human Arginase I at 1.29-Å Resolution and Exploration of Inhibition in the Immune Response
22. Relationships among Inflammatory Biomarkers and Objectively Assessed Physical Activity and Sleep during and after Chemotherapy for Gynecologic Malignancies
23. Relationships among Inflammatory Biomarkers and Self-Reported Treatment-Related Symptoms in Patients Treated with Chemotherapy for Gynecologic Cancer: A Controlled Comparison
24. Virulence, antimicrobial resistance, and dissemination of Campylobacter coli isolated from chicken carcasses in Brazil
25. c-Maf: a bad influence in the education of macrophages
26. CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint
27. Capítulo 18 - Chatbots y salud mental. Reflexiones éticas y deontológicas en torno al uso de un griefbot en un caso de duelo
28. Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
29. IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity
30. The cellular metabolic landscape in the tumor milieu regulates the activity of myeloid infiltrates
31. Defining the mechanisms of action and resistance to the anti-PD-1+LAG-3 and anti-PD-1+CTLA-4 combinations in melanoma flank and brain models
32. Supplementary Figure from TCR-Independent Metabolic Reprogramming Precedes Lymphoma-Driven Changes in T-cell Fate
33. Supplementary Table from Genomic and Single-Cell Landscape Reveals Novel Drivers and Therapeutic Vulnerabilities of Transformed Cutaneous T-cell Lymphoma
34. Data from Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4+ Th1 Responses and Potential Use as a Cancer Vaccine
35. Data from TCR-Independent Metabolic Reprogramming Precedes Lymphoma-Driven Changes in T-cell Fate
36. Supplementary Data from Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4+ Th1 Responses and Potential Use as a Cancer Vaccine
37. Supplementary Table from TCR-Independent Metabolic Reprogramming Precedes Lymphoma-Driven Changes in T-cell Fate
38. Data from Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity
39. Supplementary Figures and Table from Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity
40. Abstract 5109: The anti-PD1+anti-LAG3 and anti-CTLA4+anti-PD1 combinations have non-overlapping mechanisms of action in melanoma cranial and extra cranial metastases
41. Abstract 5703: The immune cell state atlas analysis predicts therapeutic benefits with immune checkpoint inhibitors
42. Data from Genomic and Single-Cell Landscape Reveals Novel Drivers and Therapeutic Vulnerabilities of Transformed Cutaneous T-cell Lymphoma
43. Abstract 6401: HMGB1 release predicts chemotherapy combinatorial efficacy with TIM-3 blockade
44. Figure S1-S7 and Table S1 from ABC294640, A Novel Sphingosine Kinase 2 Inhibitor, Induces Oncogenic Virus–Infected Cell Autophagic Death and Represses Tumor Growth
45. Supplemental Figure 2 from Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
46. Data from ABC294640, A Novel Sphingosine Kinase 2 Inhibitor, Induces Oncogenic Virus–Infected Cell Autophagic Death and Represses Tumor Growth
47. Data from Rescue of Notch-1 Signaling in Antigen-Specific CD8+ T Cells Overcomes Tumor-Induced T-cell Suppression and Enhances Immunotherapy in Cancer
48. Data from Sildenafil Suppresses Inflammation-Driven Colorectal Cancer in Mice
49. Supplemental Figure 4 from Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
50. Data from Targeting Sphingosine Kinase Induces Apoptosis and Tumor Regression for KSHV-Associated Primary Effusion Lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.